Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD crawled time : 15:00 save search
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.01%
H: 1.59%
C: 0.63%
antibody collaboration agreement
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Published: 2024-01-30 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.34%
H: 0.13%
C: -0.23%
yescarta fda t-cell change approval therapy
Lyndra Therapeutics Raises $101 Million in Series E Funding
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.29%
H: 0.76%
C: 0.14%
million series therapeutics funding
Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.2%
H: 1.8%
C: 1.62%
trodelvy breast symposium cancer
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
Published: 2023-09-06 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.05%
H: 0.03%
C: -1.17%
series total deal
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published: 2023-05-26 (Crawled : 15:00) - prnewswire.com
DAWN 4 | $14.98 -4.89% -5.14% 1.4M
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 4.21%
C: 3.06%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -18.22%
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.63%
C: -0.58%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.07%
H: 2.53%
C: 1.23%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.45%
H: 0.79%
C: -1.17%
asco
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Published: 2023-05-09 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -0.66%
H: 0.0%
C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.36%
H: 1.23%
C: 0.63%
lyn-005 schizophrenia trial therapeutics study
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
Published: 2023-01-03 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.9%
H: 1.25%
C: 0.36%
collaboration therapeutics
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -0.74%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -0.25%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.08%
H: 0.21%
C: -0.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 0.08%
C: -0.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.16%
C: -0.47%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.04%
H: 0.21%
C: -0.25%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 0.66%
C: 0.61%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -0.32%
H: 2.91%
C: 2.75%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: 0.01%
global disease report therapeutics cancer market
Thryv Therapeutics Inc. announces the appointment of Pharmaceutical Commercialization Expert Melissa Koomey, M.B.A., to its Board of Directors
Published: 2022-11-29 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.34%
H: 0.43%
C: 0.3%
commercialization therapeutics
Movers & Shakers: New C-Suites for Assembly Biosciences, Urica Therapeutics, BlueSphere Bio and More
Published: 2022-10-07 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.81%
H: 0.0%
C: -2.52%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.05%
H: 2.53%
C: -0.69%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.48%
H: 0.7%
C: -0.54%
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: -0.5%
H: 5.0%
C: 2.0%
Susan G. Komen® MORE THAN PINK Walk Raises Money To Improve Outcomes For Breast Cancer Patients
Published: 2022-09-22 (Crawled : 15:00) - prnewswire.com
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.24%
H: 1.52%
C: 0.66%
komen cancer
Kite’s CAR T-cell Therapy Tecartus® Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)
Published: 2022-07-22 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.43%
H: 0.86%
C: -0.77%
tecartus chmp t-cell leukemia positive therapy
Antiviral Drugs Market Size To Reach USD 50.02 BN In 2030 Due to Development Of New, Improved, And More Advanced Formulations, Such As Repurposed Drugs And Drug Combination Therapies, Says Reports and Data
Published: 2022-04-13 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -0.83%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.12%
H: 0.44%
C: 0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.24%
H: 0.53%
C: 0.18%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: -3.67%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.02%
H: 0.8%
C: 0.71%
drug antiviral repurposed market
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.32%
H: 0.31%
C: 0.06%
yescarta fda cel therapy t-cell syndros
Trodelvy® Demonstrates Clinical Benefit for Black Patients Consistent with Full Metastatic Triple-Negative Breast Cancer Population in ASCENT Study
Published: 2021-12-10 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
trodelvy cancer negative breast cancer
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Published: 2021-12-06 (Crawled : 15:00) - globenewswire.com
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
approval covid chmp covid-19
Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
Published: 2021-11-29 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
AMZN | $174.63 -2.56% -2.63% 54M
|
Retail Trade
|
| O: 1.2%
H: 0.0%
C: 0.0%
liver collaboration
BioSpace Movers & Shakers, Oct. 22
Published: 2021-10-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -0.41%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.09%
H: 1.28%
C: 1.16%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.37%
H: 1.06%
C: 0.96%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
OCUL | News | $5.22 -10.92% -12.26% 9.1M
|
Health Technology
|
| O: -27.15%
H: 0.89%
C: -12.42%
NRIX 2 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 0.43%
H: 0.11%
C: -0.81%
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
space spac
China Approves Its First Commercial CAR T-Cell Therapy
Published: 2021-06-23 (Crawled : 15:00) - biospace.com/
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.24%
H: 0.06%
C: -0.83%
china therapy t-cell approval car-t commercialization
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.